64 / 100

Dr. Toru Nishiwaki | Orthopedics | Best Researcher Award

Director of joint reconstruction center at Japanese Red Cross Shizuoka Hospital, Japan
Summary:

Dr. Toru Nishiwaki is a highly accomplished orthopedic surgeon specializing in joint reconstruction and arthroplasty, with over two decades of experience in the field. He has a strong background in both clinical practice and academic research, contributing significantly to the advancement of minimally invasive total hip arthroplasty techniques. His professional journey spans several prestigious hospitals in Japan and internationally, including fellowships in Canada, France, and Australia. As the Director of the Joint Reconstruction Center at the Shizuoka Red Cross Hospital, he continues to innovate in orthopedic surgery while leading a team of specialists. His research is well-regarded for addressing the challenges in joint replacement surgeries and enhancing patient outcomes.

Professional Profile:

👩‍🎓Education:

Keio University, School of Medicine, Tokyo, Japan

  • Apr. 1992 – Mar. 1998: Completed a Medical degree.

Keio University, Tokyo, Japan

  • May 2006: Earned a PhD in Medicine.

🏢 Professional Experience:

Dr. Toru Nishiwaki currently serves as the Director of the Joint Reconstruction Center at the Shizuoka Red Cross Hospital in Shizuoka, Japan, a position he has held since October 2018. His extensive career in orthopedic surgery began after earning his medical license in Japan in 1998.

Dr. Nishiwaki started his professional journey in 1999 at Saiseikai Utsunomiya Hospital’s Department of Orthopedic Surgery. His early career saw him rotate through various institutions, including Keio University Hospital and the National Center for Child Health and Development, where he honed his expertise in orthopedic surgery. In 2010, Dr. Nishiwaki pursued multiple international fellowships in arthroplasty and sports medicine, spending time at Ottawa University in Canada, SportsMed-SA in Australia, and in Paris as an exchange fellow under the Societe Franco-Japonaise d’Orthopedie.

From 2013 to 2018, Dr. Nishiwaki served as an Assistant Professor at Keio University Hospital’s Department of Orthopedic Surgery in Tokyo, Japan, where he gained recognition for his research in joint reconstruction and hip arthroplasty.

Research Interests:

Dr. Nishiwaki’s research primarily focuses on joint reconstruction, hip arthroplasty, osteoarthritis, and fracture management. His work encompasses various aspects of orthopedic surgery, including the biomechanics of joint replacement, minimally invasive techniques, and the complications related to hip surgeries such as venous thromboembolism and pelvic tilt displacement. He is also engaged in research on bone regeneration, the role of insulin-like growth factor in muscle volume maintenance, and advanced techniques like curved periacetabular osteotomy. His interest in international collaboration is evident in his contributions to orthopedic research in both Japan and abroad.

Author Metrics:

Dr. Nishiwaki has authored and co-authored numerous peer-reviewed articles in high-impact journals, contributing significantly to the field of orthopedic surgery. Some of his notable publications include:

  1. Pain characteristics in patients with hip osteoarthritis (Journal of Joint Surgery Research, 2024).
  2. Higher incidence of venous thromboembolism in the anterolateral approach of minimally invasive total hip arthroplasty (Cureus, 2024).
  3. Short-term outcomes of total hip arthroplasty after liver transplantation (Arthroplasty Today, 2021).
  4. Insulin-like growth factor-I is required to maintain muscle volume in adult mice (Journal of Bone and Mineral Metabolism, 2019).
  5. Pelvic tilt displacement before and after artificial hip joint replacement surgery (Journal of Arthroplasty, 2018).

Dr. Nishiwaki has an h-index of 12 and his research has been cited in orthopedic surgery literature for its impact on improving surgical techniques and patient care in hip and joint replacements. His contributions have earned him the Iwahara Award in Orthopedic Surgery from Keio University in 2006.

Top Noted Publication:

  • Title: Short-Term Outcomes of Total Hip Arthroplasty after Liver Transplantation
    Authors: Oya, A.; Umezu, T.; Ogawa, R.; Matsumoto, M.; Kanaji, A.
    Journal: Arthroplasty Today
    Year: 2021
    Volume: 8
    Pages: 11–14
    Citations: 8
    Abstract: The abstract is not available in the provided content, but the study focuses on the short-term outcomes of patients undergoing total hip arthroplasty after liver transplantation.
  • Title: Insulin-like growth factor-I is required to maintain muscle volume in adult mice
    Authors: Nakamura, S.; Sato, Y.; Kobayashi, T.; Kanaji, A.; Miyamoto, T.
    Journal: Journal of Bone and Mineral Metabolism
    Year: 2019
    Volume: 37
    Issue: 4
    Pages: 627–635
    Citations: 14
    Abstract: The abstract is not provided, but this article explores the role of Insulin-like growth factor-I (IGF-I) in maintaining muscle volume in adult mice.
  • Title: Curved periacetabular osteotomy via a novel intermuscular approach between the sartorius and iliac muscles
    Authors: Nishiwaki, T.; Oya, A.; Fukuda, S.; Matsumoto, M.; Kanaji, A.
    Journal: HIP International
    Year: 2018
    Volume: 28
    Issue: 6
    Pages: 642–648
    Citations: 6
    Abstract: This paper presents a novel intermuscular approach for performing curved periacetabular osteotomy, which is a surgical procedure for treating hip dysplasia.
  • Title: Tumor necrosis factor receptor-associated factor 6 is required to inhibit foreign body giant cell formation and activate osteoclasts under inflammatory and infectious conditions
    Authors: Oya, A.; Katsuyama, E.; Morita, M.; Kanaji, A.; Miyamoto, T.
    Journal: Journal of Bone and Mineral Metabolism
    Year: 2018
    Volume: 36
    Issue: 6
    Pages: 679–690
    Citations: 12
    Abstract: The study investigates the role of Tumor Necrosis Factor Receptor-Associated Factor 6 (TRAF6) in preventing the formation of foreign body giant cells and activating osteoclasts in inflammatory and infectious environments.
  • Title: Neuroblastoma metastasis to bone requiring differentiation from septic arthritis of the hip. Report of 2 cases
    Authors: Nishiwaki, T.; Uchikawa, S.; Kusakabe, H.; Matsumoto, M.; Kanaji, A.
    Journal: Journal of Orthopaedic Science
    Year: 2018
    Volume: 23
    Issue: 5
    Pages: 853–856
    Citations: 1
    Abstract: This paper reports two cases where neuroblastoma metastasis to bone required differentiation from septic arthritis of the hip.

Conclusion:

Dr. Toru Nishiwaki is a highly qualified candidate for the Best Researcher Award in Orthopedics, given his innovative contributions to joint reconstruction and hip arthroplasty. His extensive experience, international collaborations, and research impact make him a strong contender. With further expansion of his research scope and enhanced global visibility, he could solidify his standing as one of the leading figures in orthopedic surgery and research.

 

 

 

Toru Nishiwaki | Orthopedics | Best Researcher Award

You May Also Like